Gregory C Kane – författare

This book is a comprehensive guide to lung cancer screening for clinicians, healthcare systems, community leaders, and public health officials with the hope of creating a more equitable landscape in both lung cancer screening and lung cancer-related outcomes, at local, state, and national levels. Authors take a new approach to primary and secondary lung cancer prevention that is in the early stages of adoption in the United States. The last decade ushered in recognition of screening as an effective intervention, but unfortunately, despite the wide acceptance of the importance of this new screening modality, nationally, not more than 5% of eligible subjects have undergone screening to date in the United States, although in some states uptake has reached as high as 16%. As is common with any new preventive cancer screening, racial and socioeconomic disparities emerge in utilization, stage at diagnosis, and mortality. Over time, these disparities decline, but consequential differences endure. Therefore, it is critical to establish equitable screening practices. The true measure of the effectiveness of any lung cancer screening program needs to be viewed through the lens of its impact on populations, including those most affected by the morbidity and mortality of smoking-related illness and lung cancer. As such, this book emphasizes a number of important public health topics, including community outreach to vulnerable populations, social justice issues, addressing stigma and fatalism in the general community, and the use of geocoding to assess a program’s impact at a population level. This book weaves traditional topics related to lung cancer screening, such as promoting initial and repeat screening, interpreting Lung RADs, and managing the follow-up of findings, into the population perspective in order to present a unified, comprehensive approach to the subject. Further, it serves as a guide that health systems, health care professionals, community leaders, and other stakeholders can use to achieve the promise of lung cancer screening.

This book is a comprehensive guide to lung cancer screening for clinicians, healthcare systems, community leaders, and public health officials with the hope of creating a more equitable landscape in both lung cancer screening and lung cancer-related outcomes, at local, state, and national levels. Authors take a new approach to primary and secondary lung cancer prevention that is in the early stages of adoption in the United States. The last decade ushered in recognition of screening as an effective intervention, but unfortunately, despite the wide acceptance of the importance of this new screening modality, nationally, not more than 5% of eligible subjects have undergone screening to date in the United States, although in some states uptake has reached as high as 16%. As is common with any new preventive cancer screening, racial and socioeconomic disparities emerge in utilization, stage at diagnosis, and mortality. Over time, these disparities decline, but consequential differences endure. Therefore, it is critical to establish equitable screening practices. The true measure of the effectiveness of any lung cancer screening program needs to be viewed through the lens of its impact on populations, including those most affected by the morbidity and mortality of smoking-related illness and lung cancer. As such, this book emphasizes a number of important public health topics, including community outreach to vulnerable populations, social justice issues, addressing stigma and fatalism in the general community, and the use of geocoding to assess a program’s impact at a population level. This book weaves traditional topics related to lung cancer screening, such as promoting initial and repeat screening, interpreting Lung RADs, and managing the follow-up of findings, into the population perspective in order to present a unified, comprehensive approach to the subject. Further, it serves as a guide that health systems, health care professionals, community leaders, and other stakeholders can use to achieve the promise of lung cancer screening.

This book puts forward a comprehensive text that addresses routine uses of oxygen as a therapeutic modality as well as utilization of supplemental oxygen and advanced support of academic respiratory failure in the sickest patients with hypoxemia seeking care in medical centers. These centers range from rural or safety net hospitals to the most advanced academic medical centers. Oxygen supplementation may be one of the most commonly applied therapeutic modalities utilized in modern medicine.  Despite this, a comprehensive discussion of the practical application of supplemental oxygen has often been limited to treatises that deal with the very advanced forms lung disease without educating the reader on the basics of oxygen in human physiology and the full spectrum of human illnesses that compromise oxygen delivery to the host. As highlighted by the recent pandemic, there are growing number of tools to improve oxygenation.  The authors cover both harmful effects of oxygen delivery, beneficial effects, and a careful description of the risks and benefits to understand when advanced techniques can be life-saving and when they should be avoided. In 2018, a meta-analysis addressed the use of simple supplemental oxygen in a number of routine diagnoses including pneumonia, myocardial infarction, sepsis and stroke.  The authors put this very important background into context for the modern physician guiding them on the appropriate use of oxygen to avoid the pitfall of increasing mortality without affecting important patient outcomes. Every practicing physician should be aware of the benefits of oxygen therapy, but must also understand the harms and how to avoid overuse.Beyond routine therapeutics, the authors review the use of oxygen in SCUBA and mountaineering so that the recreational enthusiast and the physician treating such individuals can be ready to understand the pathophysiology and therapeutic options available to the clinician.  The authors also include chapters covering special disease states such as sleep apnea, carbon dioxide poisoning and methemoglobinemia to understand how these conditions can reduce oxygen delivery and lead to significant morbidity and even mortality.This is an ideal guide for all medical professionals who use oxygen to treat and help their patients.